M&A Transaction

Apax Acquires Gerresheimer Plastics for €1.5 Billion

Apax Partners secures €1.5 billion deal for Gerresheimer's plastic packaging businesses, Primary Packaging Plastics and Centor, bolstering its portfolio.

Share:
AM
Alvaro de la Maza

Partner at Aninver

Stay ahead of the market

Get instant notifications when new news matching "Manufacturing, Healthcare, Healthtech & Medtech in Germany, United States" are published.

Key Takeaways

  • Apax acquired Gerresheimer, Centor for $1.5B.
  • Sector: Manufacturing, Healthcare, Healthtech & Medtech.
  • Geography: Germany, United States.

Analysis

Apax Partners has agreed to acquire two significant plastic packaging divisions from German manufacturer Gerresheimer in a carve-out transaction valued at approximately €1.5 billion, including debt. This strategic divestment by Gerresheimer aims to bolster its financial standing and streamline operations following a period of internal review and accounting scrutiny.

The acquired entities comprise Gerresheimer’s global Primary Packaging Plastics business and the U.S.-based specialist Centor. These operations collectively generated roughly €570 million in revenue last fiscal year and employ around 2,400 individuals. The deal encompasses 15 manufacturing sites across nine countries for the Primary Packaging Plastics division, alongside Centor's production facility in the United States, underscoring the global reach of the divested assets.

This transaction is a key component of Gerresheimer's broader strategic realignment. The company has been actively working to strengthen its balance sheet and reduce its debt burden. The proceeds from this sale are earmarked for deleveraging, a move that signals a renewed focus on financial health and operational efficiency. Gerresheimer had previously announced plans to divest Centor earlier this year as part of this financial fortification strategy.

The divestiture occurs against a backdrop of recent challenges for Gerresheimer, including delays in financial reporting stemming from an internal accounting investigation. These issues led to the company's removal from the SDAX index and prompted audits by Germany's financial regulator, BaFin. While the internal investigation has concluded, Gerresheimer is still assessing potential claims related to these accounting matters. Earlier this year, the company also reportedly declined an unsolicited acquisition approach from rival Silgan, prioritizing its internal restructuring and asset disposal program.

The plastic packaging sector, particularly for pharmaceutical applications, remains a critical segment within the broader healthcare and manufacturing industries. Demand for high-quality, compliant packaging solutions continues to grow, driven by an aging global population and increasing healthcare access. Companies like Gerresheimer and its competitors operate in a market characterized by stringent regulatory requirements and a constant need for innovation in materials and design. The carve-out by Apax suggests a belief in the standalone potential and future growth prospects of these specific plastic packaging assets.

Completion of the Centor acquisition is anticipated before the close of Gerresheimer's 2026 fiscal year. The sale of the Primary Packaging Plastics division is expected to finalize in the first half of 2027. This phased approach allows for a structured transition of operations and integration into Apax's portfolio, which often focuses on operational improvements and strategic growth initiatives for its acquired companies.